Selective Proteolysis of Activated Transcriptional Factor by NIR-Responsive Palindromic DNA Thalidomide Conjugate

Min Hou1,2, Rui Guo1, Tianyu Ren1

  • 1State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biomedical Sciences, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China.

Insights

A novel palindromic DNA conjugate (PASTE) selectively degrades activated transcription factors, offering a new approach for hard-to-drug targets. This PROTAC technology shows promise for precision medicine and studying disease pathways.

Area of Science:

  • Molecular Biology
  • Drug Discovery
  • Biochemistry

Background:

  • Dysfunctional transcription factors drive disease progression by altering protein expression.
  • Targeting transcription factors is challenging due to a lack of druggable sites.
  • Proteolysis targeting chimeras (PROTACs) offer a promising strategy for previously undruggable targets.

Purpose of the Study:

  • To develop a novel PROTAC technology for selective degradation of activated transcription factors.
  • To validate the efficacy of the palindromic double-strand DNA thalidomide conjugate (PASTE) in degrading target proteins.
  • To explore advanced delivery and activation methods for PROTACs.

Main Methods:

  • Design and synthesis of a palindromic double-strand DNA thalidomide conjugate (PASTE).
  • Demonstration of selective proteolysis of dimerized phosphorylated receptor-regulated Smad2/3.
  • Validation of canonical Smad pathway inhibition.
  • Development of aptamer-guided active delivery and near-infrared light-triggered PROTAF.

Main Results:

  • PASTE successfully induced selective proteolysis of the targeted activated transcription factor (PROTAF).
  • The canonical Smad pathway was effectively inhibited, validating PASTE's mechanism.
  • Aptamer-guided delivery and light-triggered activation of PASTE were successfully demonstrated.
  • PASTE proved effective in degrading activated transcription factors.

Conclusions:

  • PASTE represents a powerful new tool for the selective degradation of activated transcription factors.
  • This technology has significant potential for advancing the study of signaling pathways.
  • PASTE offers a promising avenue for the development of novel precision medicines.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K